Ashland Global Holdings Inc(NYSE:ASH) 
Ashland Global Holdings Inc. provides specialty chemical solutions worldwide. The company's Specialty Ingredients segment offers products, technologies, and resources for solving formulation and product-performance challenges. It provides solutions using natural, synthetic, and semisynthetic polymer...
Website: http://www.ashland.com
Founded: 1924
Full Time Employees: 4,500
CEO: Guillermo Novo
Sector: Basic Materials
Industry: Chemicals
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sales - note p | 336,750,000 | 463,000,000 | 479,000,000 | 405,000,000 | ||||||||||||||||||||||||||||||||
cost of sales | 239,250,000 | 331,000,000 | 332,000,000 | 294,000,000 | 348,000,000 | 358,000,000 | 414,000,000 | 375 | 389,000,000 | 368,000,000 | 406,000,000 | 360,000,000 | 422,000,000 | 404,000,000 | 384,000,000 | 351,000,000 | 221,000,000 | 439,000,000 | 407,000,000 | 374,000,000 | 448,000,000 | 378,000,000 | 413,000,000 | 380,000,000 | 399,000,000 | 434,000,000 | 469,000,000 | 424,000,000 | 675,000,000 | 681,000,000 | 699,000,000 | 613,000,000 | 645,000,000 | 635,000,000 | 887,000,000 | 807,000,000 |
gross profit | 97,500,000 | 132,000,000 | 147,000,000 | 111,000,000 | 174,000,000 | 186,000,000 | 161,000,000 | 128,000,000 | 178,000,000 | 197,000,000 | 165,000,000 | 210,000,000 | 240,000,000 | 220,000,000 | 161,000,000 | 104,000,000 | 198,000,000 | 191,000,000 | 178,000,000 | 161,000,000 | 196,000,000 | 197,000,000 | 153,000,000 | 210,000,000 | 207,000,000 | 198,000,000 | 152,000,000 | 281,000,000 | 290,000,000 | 275,000,000 | 229,000,000 | 235,000,000 | 235,000,000 | 433,000,000 | 386,000,000 | |
yoy | -43.97% | -29.03% | -8.70% | 35.94% | 4.49% | -18.27% | -39.05% | -25.83% | -10.45% | 2.48% | 101.92% | 21.21% | 15.18% | -9.55% | -35.40% | 1.02% | -3.05% | 16.34% | -23.33% | -5.31% | -0.51% | 0.66% | -25.27% | -28.62% | -28.00% | -33.62% | 19.57% | 23.40% | -36.49% | -40.67% | ||||||
qoq | -26.14% | -10.20% | 32.43% | -36.21% | -6.45% | 15.53% | -28.09% | -9.64% | 19.39% | -21.43% | -12.50% | 9.09% | 36.65% | 54.81% | -47.47% | 3.66% | 7.30% | 10.56% | -17.86% | -0.51% | 28.76% | -27.14% | 1.45% | 4.55% | 30.26% | -45.91% | -3.10% | 5.45% | 20.09% | -2.55% | 0.00% | -45.73% | 12.18% | |||
selling, general and administrative expense | 67,000,000 | 106,000,000 | 85,000,000 | 78,000,000 | 101,000,000 | 114,000,000 | 106,000,000 | 109,000,000 | 84,000,000 | 79,000,000 | 93,000,000 | 94,000,000 | 127,000,000 | 90,000,000 | 82,000,000 | 69,000,000 | 98,000,000 | 84,000,000 | 106,000,000 | 109,000,000 | 113,000,000 | 103,000,000 | 120,000,000 | 110,000,000 | 150,000,000 | 136,000,000 | 143,000,000 | 234,000,000 | 203,000,000 | 163,000,000 | 171,000,000 | 177,000,000 | 182,000,000 | 245,000,000 | 239,000,000 | |
research and development expense | 10,250,000 | 13,000,000 | 14,000,000 | 13,000,000 | 13,000,000 | 15,000,000 | 14,000,000 | 14,000,000 | 12,000,000 | 12,000,000 | 13,000,000 | 15,000,000 | 14,000,000 | 13,000,000 | 13,000,000 | 6,000,000 | 15,000,000 | 14,000,000 | 15,000,000 | 16,000,000 | 14,000,000 | 18,000,000 | 16,000,000 | 15,000,000 | 17,000,000 | 17,000,000 | 17,000,000 | 21,000,000 | 21,000,000 | 21,000,000 | 21,000,000 | 22,000,000 | 20,000,000 | 24,000,000 | 23,000,000 | |
intangibles amortization expense - note g | 11,750,000 | 15,000,000 | 15,000,000 | 17,000,000 | 17,000,000 | 19,000,000 | 23,000,000 | 24,000,000 | 23,000,000 | 23,000,000 | ||||||||||||||||||||||||||
equity and other income | 250,000 | 1,000,000 | 3,000,000 | 2,000,000 | 4,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 5,000,000 | 1,000,000 | 7,000,000 | 1,000,000 | 3,000,000 | -1,000,000 | 1,000,000 | 1,000,000 | 4,000,000 | 2,000,000 | -2,000,000 | 4,000,000 | 6,000,000 | 13,000,000 | ||||||||||||
goodwill impairment - note g | 176,500,000 | 706,000,000 | 132,500,000 | 530,000,000 | ||||||||||||||||||||||||||||||||
loss on acquisitions and divestitures, net - note b | 41,250,000 | -183,000,000 | -25,000,000 | -99,000,000 | ||||||||||||||||||||||||||||||||
operating income | -209,000,000 | -708,000,000 | 51,000,000 | -179,000,000 | 31,000,000 | -61,000,000 | 21,000,000 | -18 | -10,000,000 | 62,000,000 | 83,000,000 | 37,000,000 | 121,000,000 | 77,000,000 | 93,000,000 | 42,000,000 | 7,000,000 | 62,000,000 | 71,000,000 | 41,000,000 | 15,000,000 | 48,000,000 | -468,000,000 | 17,000,000 | 86,000,000 | 43,000,000 | 44,000,000 | -7,000,000 | 27,000,000 | 66,000,000 | 95,000,000 | 39,000,000 | 34,000,000 | 37,000,000 | 170,000,000 | 137,000,000 |
yoy | -774.19% | 1060.66% | 142.86% | 994444344.44% | -410.00% | -198.39% | -74.70% | -100.00% | -108.26% | -19.48% | -10.75% | -11.90% | 1628.57% | 24.19% | 30.99% | 2.44% | -53.33% | 29.17% | -115.17% | 141.18% | -82.56% | 11.63% | -1163.64% | -342.86% | 218.52% | -34.85% | -53.68% | -117.95% | -20.59% | 78.38% | -44.12% | -71.53% | ||||
qoq | -70.48% | -1488.24% | -128.49% | -677.42% | -150.82% | -390.48% | -116666766.67% | -100.00% | -116.13% | -25.30% | 124.32% | -69.42% | 57.14% | -17.20% | 121.43% | 500.00% | -88.71% | -12.68% | 73.17% | 173.33% | -68.75% | -110.26% | -2852.94% | -80.23% | 100.00% | -2.27% | -728.57% | -125.93% | -59.09% | -30.53% | 143.59% | 14.71% | -8.11% | -78.24% | 24.09% | |
net interest and other income | 8,500,000 | -5,000,000 | 11,000,000 | 28,000,000 | -3,500,000 | 7,000,000 | 2,000,000 | -5,250,000 | 3,000,000 | -10,000,000 | -14,000,000 | 27,000,000 | 59,000,000 | 43,000,000 | 5,000,000 | 4,500,000 | 1,000,000 | 23,000,000 | -6,000,000 | 28,250,000 | -14,000,000 | 117,000,000 | 10,000,000 | 18,250,000 | 21,000,000 | -3,000,000 | ||||||||||
other net periodic benefit loss - note k | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 1,500,000 | 2,000,000 | 1,500,000 | 2,000,000 | -1,000,000 | |||||||||||||||||||||||||||
income from continuing operations before income taxes | -218,500,000 | -704,000,000 | 39,000,000 | -209,000,000 | 25,000,000 | -70,000,000 | 17,000,000 | -37,000,000 | 57,000,000 | 91,000,000 | 50,000,000 | 60,000,000 | 52,000,000 | 58,000,000 | 37,000,000 | -33,000,000 | 63,000,000 | 43,000,000 | 61,000,000 | 9,000,000 | 62,000,000 | -585,000,000 | 10,000,000 | 49,000,000 | 22,000,000 | 46,000,000 | -47,000,000 | 9,000,000 | 31,000,000 | 67,000,000 | 7,000,000 | 132,000,000 | 4,000,000 | |||
income tax benefit - note j | -4,750,000 | 15,000,000 | 9,000,000 | -43,000,000 | -57,250,000 | -101,000,000 | -1,000,000 | |||||||||||||||||||||||||||||
income from continuing operations | -213,750,000 | -719,000,000 | 30,000,000 | -166,000,000 | 19,000,000 | 31,000,000 | 121,000,000 | 28 | -8,000,000 | 42,000,000 | 92,000,000 | 42,000,000 | 60,000,000 | 51,000,000 | 38,000,000 | 32,000,000 | -17,000,000 | 87,000,000 | 43,000,000 | 61,000,000 | 50,000,000 | -575,000,000 | 34,000,000 | 27,000,000 | 23,000,000 | 45,000,000 | -71,000,000 | 10,000,000 | 36,000,000 | 66,000,000 | -0.12 | 102,000,000 | 10,000,000 | |||
income from discontinued operations, net of income taxes - note c | -5,500,000 | -23,000,000 | 1,000,000 | 1,000,000 | -3,000,000 | -25,000,000 | ||||||||||||||||||||||||||||||
net income | -219,250,000 | -742,000,000 | 31,000,000 | -165,000,000 | 16,000,000 | 6,000,000 | 120,000,000 | 26 | -4,000,000 | 50,000,000 | 91,000,000 | 40,000,000 | 57,000,000 | 36,000,000 | 786,000,000 | 48,000,000 | 44,000,000 | 80,000,000 | 41,000,000 | 56,000,000 | 5,000,000 | 37,000,000 | -582,000,000 | 32,000,000 | 411,000,000 | 66,000,000 | 76,000,000 | -48,000,000 | 10,000,000 | 36,000,000 | 73,000,000 | -4 | -57,000,000 | -30 | 105,000,000 | 10,000,000 |
yoy | -1470.31% | -12466.67% | -74.17% | -634615484.62% | -500.00% | -88.00% | 31.87% | -100.00% | -107.02% | 38.89% | -88.42% | -16.67% | 29.55% | -55.00% | 1817.07% | -14.29% | 780.00% | 116.22% | -107.04% | 75.00% | -98.78% | -43.94% | -865.79% | -166.67% | 4010.00% | 83.33% | 4.11% | 1199999900.00% | -117.54% | -120000100.00% | -30.48% | -100.00% | ||||
qoq | -70.45% | -2493.55% | -118.79% | -1131.25% | 166.67% | -95.00% | 461538361.54% | -100.00% | -108.00% | -45.05% | 127.50% | -29.82% | 58.33% | -95.42% | 1537.50% | 9.09% | -45.00% | 95.12% | -26.79% | 1020.00% | -86.49% | -106.36% | -1918.75% | -92.21% | 522.73% | -13.16% | -258.33% | -580.00% | -72.22% | -50.68% | -1825000100.00% | -100.00% | 189999900.00% | -100.00% | 950.00% | |
per share data | ||||||||||||||||||||||||||||||||||||
basic earnings per share - note m | ||||||||||||||||||||||||||||||||||||
income from discontinued operations | -0.115 | -0.51 | 0.02 | 0.01 | -0.06 | -0.49 | -0.01 | 0.07 | 0.15 | -0.01 | -0.03 | 0.05 | -0.28 | 13.23 | 0.29 | 14,000,000.78 | -7,000,000 | -2,000,000 | -5,000,000 | 21,999,999.71 | -13,000,000 | -7,000,000 | -2,000,000 | 24,250,000 | 43,000,000 | 31,000,000 | 23,000,000 | 2,250,000 | 7,000,000 | 0.445 | 0.05 | |||||
diluted earnings per share - note m | ||||||||||||||||||||||||||||||||||||
comprehensive income | -207.25 | -652 | 82 | -258 | 67 | -17 | 94 | -37 | 47 | 115 | 118 | -31 | -53 | 786 | 28 | 18 | 103 | 7 | 104 | 39 | 44 | -634 | 70 | 369 | 69 | 67 | -85 | 19 | -102 | 122 | 7 | 10 | 79 | 169 | ||
other comprehensive income, net of tax | ||||||||||||||||||||||||||||||||||||
unrealized translation gain | 11.5 | 91 | 49 | -94 | 52 | -25 | -27 | -33 | -4 | 27 | 82 | -90 | -86 | -5 | -17 | -30 | 23 | -34 | 48 | 34 | 7 | -52 | 38 | -43 | 3 | -9 | -31 | -140 | 55 | 3 | 62 | 105 | 60 | |||
unrealized gain on commodity hedges | 0.5 | -1 | 2 | 1 | -1 | 2 | 1 | 1 | -3 | -0.5 | -3 | 5 | ||||||||||||||||||||||||
other comprehensive income - note n | 12 | 90 | 51 | -93 | 1 | -23 | 24.75 | -3 | 24 | 78 | -27.25 | -89 | -20 | |||||||||||||||||||||||
income on acquisitions and divestitures, net - note b | 18,000,000 | 10,500,000 | 35,000,000 | |||||||||||||||||||||||||||||||||
sales | 522,000,000 | 544,000,000 | 575,000,000 | 517,000,000 | 546,000,000 | 603,000,000 | 525,000,000 | 632,000,000 | 644,000,000 | 604,000,000 | 512,000,000 | 325,000,000 | 637,000,000 | 598,000,000 | 552,000,000 | 609,000,000 | 574,000,000 | 610,000,000 | 533,000,000 | 609,000,000 | 641,000,000 | 667,000,000 | 576,000,000 | 956,000,000 | 971,000,000 | 974,000,000 | 842,000,000 | 880,000,000 | 870,000,000 | 1,320,000,000 | 1,193,000,000 | |||||
intangibles amortization expense - note f | 20,000,000 | |||||||||||||||||||||||||||||||||||
loss on acquisitions and divestitures | ||||||||||||||||||||||||||||||||||||
other net periodic benefit loss - note j | 2,000,000 | |||||||||||||||||||||||||||||||||||
income tax benefit - note i | -104,000,000 | 14,000,000 | ||||||||||||||||||||||||||||||||||
income from discontinued operations, net of income taxes - note b | -1,000,000 | |||||||||||||||||||||||||||||||||||
basic earnings per share - note l | ||||||||||||||||||||||||||||||||||||
diluted earnings per share - note l | ||||||||||||||||||||||||||||||||||||
other comprehensive income - note m | -26 | |||||||||||||||||||||||||||||||||||
life sciences | 42 | |||||||||||||||||||||||||||||||||||
personal care | 27 | |||||||||||||||||||||||||||||||||||
specialty additives | 26 | |||||||||||||||||||||||||||||||||||
intermediates | 5 | |||||||||||||||||||||||||||||||||||
diluted earnings per share net income | 0.51 | |||||||||||||||||||||||||||||||||||
diluted earnings per share income from continuing operations | 0.54 | |||||||||||||||||||||||||||||||||||
ebitda | 34 | |||||||||||||||||||||||||||||||||||
adjusted ebitda | 70 | |||||||||||||||||||||||||||||||||||
adjusted diluted eps from continuing operations excluding intangibles amortization expense | 0.45 | |||||||||||||||||||||||||||||||||||
gross profit as a percent of sales | 20.7 | |||||||||||||||||||||||||||||||||||
income tax expense - note j | 5,250,000 | 15,000,000 | 8,000,000 | |||||||||||||||||||||||||||||||||
income from discontinued operations (net of income taxes) - note c | 1,500,000 | 8,000,000 | -1,000,000 | -2,000,000 | 187,250,000 | -15,000,000 | 748,000,000 | 16,000,000 | ||||||||||||||||||||||||||||
other net periodic benefit loss | 2,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||
unrealized loss on commodity hedges | -4 | -3 | ||||||||||||||||||||||||||||||||||
intangibles amortization expense | 17,750,000 | 23,000,000 | 24,000,000 | 24,000,000 | 24,000,000 | 24,000,000 | 22,000,000 | 21,000,000 | 22,000,000 | 21,000,000 | 21,000,000 | |||||||||||||||||||||||||
income tax benefit | 6,250,000 | 1,000,000 | 20,000,000 | 5,000,000 | -5,500,000 | -24,000,000 | -5,250,000 | 12,000,000 | -10,000,000 | -24,000,000 | 6,000,000 | -1,000,000 | 1,000,000 | 2,500,000 | -5,000,000 | 1,000,000 | ||||||||||||||||||||
other net periodic benefit income - note k | 1,000,000 | |||||||||||||||||||||||||||||||||||
income on acquisitions and divestitures | 7,000,000 | |||||||||||||||||||||||||||||||||||
net income on acquisitions and divestitures | 2,750,000 | 2,000,000 | -5,000,000 | -750,000 | -2,000,000 | |||||||||||||||||||||||||||||||
goodwill impairment | ||||||||||||||||||||||||||||||||||||
other net periodic benefit income | 250,000 | 250,000 | 4,250,000 | -1,000,000 | 18,000,000 | 250,000 | 1,000,000 | |||||||||||||||||||||||||||||
other comprehensive income | -26 | 23 | -34 | 48 | 34 | 7 | -52 | 38 | -42 | 3 | -9 | -37 | 9 | -138 | 49 | 11 | 67 | 109 | 64 | |||||||||||||||||
net income on divestitures | 14,000,000 | 750,000 | 3,000,000 | -750,000 | 3,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||
pension and postretirement obligation adjustment | 1 | -6 | ||||||||||||||||||||||||||||||||||
net change in investment securities | ||||||||||||||||||||||||||||||||||||
net interest and other financing expense | 55,000,000 | 23,250,000 | 33,000,000 | 29,000,000 | 31,000,000 | 50,750,000 | 51,000,000 | 38,000,000 | 132,000,000 | |||||||||||||||||||||||||||
income tax expense | 24,000,000 | |||||||||||||||||||||||||||||||||||
other comprehensive loss, net of tax | ||||||||||||||||||||||||||||||||||||
net income attributable to noncontrolling interest | 3,000,000 | 13,000,000 | 11,000,000 | |||||||||||||||||||||||||||||||||
net income attributable to ashland | 10,000,000 | 36,000,000 | 73,000,000 | -4,000,000 | -57,000,000 | -33,000,000 | 92,000,000 | -1,000,000 | ||||||||||||||||||||||||||||
income from discontinued operations attributable to ashland | -0.02 | 0.11 | 0.05 | |||||||||||||||||||||||||||||||||
net change in available-for-sale securities | 9 | 2 | -6 | 8 | 5 | 4 | 6 | |||||||||||||||||||||||||||||
comprehensive income attributable to noncontrolling interest | 3 | 14 | 10 | |||||||||||||||||||||||||||||||||
comprehensive income attributable to ashland | 19 | -102 | 122 | 7 | 10 | 76 | 155 | -147 | ||||||||||||||||||||||||||||
income from discontinued operations (net of tax) - note d | 3,000,000 | 3,000,000 | ||||||||||||||||||||||||||||||||||
other comprehensive income, net of tax - note m | ||||||||||||||||||||||||||||||||||||
net gain on acquisitions and divestitures | ||||||||||||||||||||||||||||||||||||
before income taxes | ||||||||||||||||||||||||||||||||||||
(net of tax) - note d | 34,500,000 | |||||||||||||||||||||||||||||||||||
attributable to ashland | -0.213 | -0.26 | ||||||||||||||||||||||||||||||||||
dividends paid per common share | 0.251 | 0.225 | 0.39 | 0.39 | ||||||||||||||||||||||||||||||||
income tax expense - note i | 30,000,000 | |||||||||||||||||||||||||||||||||||
income from continuing operations attributable to ashland | 1.43 | -0.01 | ||||||||||||||||||||||||||||||||||
net gain on divestitures | ||||||||||||||||||||||||||||||||||||
unrealized translation loss | ||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities | ||||||||||||||||||||||||||||||||||||
other comprehensive loss |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||||
current assets | |||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 215,000,000 | 207,000,000 | 168,000,000 | 219,000,000 | 300,000,000 | 399,000,000 | 439,000,000 | 440,000,000 | 417,000,000 | 349,000,000 | 399,000,000 | 532,000,000 | 646,000,000 | 629,000,000 | 964,000,000 | 194,000,000 | 210,000,000 | 262,000,000 | 373,000,000 | 335,000,000 | 454,000,000 | 416,000,000 | 353,000,000 | 157,000,000 | 232,000,000 | 132,000,000 | 164,000,000 | 149,000,000 | 294,000,000 | 182,000,000 | 225,000,000 | 601,000,000 | 566,000,000 | 492,000,000 | 605,000,000 | 704,000,000 | 1,188,000,000 |
accounts receivable, net(a) - notes a and h | 242,000,000 | ||||||||||||||||||||||||||||||||||||
inventories - note a | 568,000,000 | 545,000,000 | 626,000,000 | 629,000,000 | 473,000,000 | 529,000,000 | 597,000,000 | 663,000,000 | 634,000,000 | 671,000,000 | |||||||||||||||||||||||||||
other assets | 180,000,000 | 149,000,000 | 139,000,000 | 127,000,000 | 107,000,000 | 189,000,000 | 178,000,000 | 143,000,000 | 125,000,000 | 120,000,000 | 107,000,000 | 117,000,000 | 91,000,000 | 91,000,000 | 77,000,000 | 66,000,000 | 68,000,000 | 72,000,000 | 86,000,000 | 100,000,000 | 87,000,000 | 121,000,000 | 119,000,000 | 53,000,000 | 64,000,000 | 47,000,000 | 63,000,000 | 62,000,000 | 74,000,000 | 144,000,000 | 122,000,000 | 92,000,000 | 91,000,000 | 73,000,000 | 113,000,000 | 106,000,000 | 113,000,000 |
total current assets | 1,205,000,000 | 1,124,000,000 | 1,075,000,000 | 1,069,000,000 | 1,195,000,000 | 1,385,000,000 | 1,427,000,000 | 1,365,000,000 | 1,506,000,000 | 1,526,000,000 | 1,631,000,000 | 1,724,000,000 | 1,768,000,000 | 1,817,000,000 | 2,025,000,000 | 1,734,000,000 | 1,717,000,000 | 1,235,000,000 | 1,418,000,000 | 1,381,000,000 | 1,547,000,000 | 1,670,000,000 | 1,645,000,000 | 1,344,000,000 | 1,433,000,000 | 2,037,000,000 | 2,087,000,000 | 1,991,000,000 | 1,712,000,000 | 1,672,000,000 | 1,713,000,000 | 1,964,000,000 | 1,903,000,000 | 1,839,000,000 | 2,377,000,000 | 2,334,000,000 | 2,866,000,000 |
noncurrent assets | |||||||||||||||||||||||||||||||||||||
property, plant and equipment - note f | |||||||||||||||||||||||||||||||||||||
cost | 3,355,000,000 | 3,336,000,000 | 3,261,000,000 | 3,227,000,000 | 3,316,000,000 | 3,265,000,000 | 3,299,000,000 | 3,277,000,000 | 3,211,000,000 | 3,191,000,000 | 3,164,000,000 | 3,116,000,000 | 3,050,000,000 | 3,065,000,000 | 3,081,000,000 | 3,070,000,000 | 3,066,000,000 | 3,343,000,000 | 3,307,000,000 | 3,310,000,000 | 3,265,000,000 | 3,203,000,000 | 3,172,000,000 | 3,155,000,000 | 3,165,000,000 | 3,196,000,000 | 3,167,000,000 | 3,195,000,000 | 3,847,000,000 | 3,826,000,000 | 3,859,000,000 | 3,795,000,000 | 3,762,000,000 | 3,707,000,000 | 4,364,000,000 | 4,283,000,000 | 4,343,000,000 |
accumulated depreciation | 2,154,000,000 | 2,135,000,000 | 2,041,000,000 | 1,993,000,000 | 2,013,000,000 | 1,971,000,000 | 1,959,000,000 | 1,910,000,000 | 1,838,000,000 | 1,837,000,000 | 1,813,000,000 | 1,770,000,000 | 1,712,000,000 | 1,713,000,000 | 1,701,000,000 | 1,669,000,000 | 1,639,000,000 | 1,819,000,000 | 1,775,000,000 | 1,748,000,000 | 1,700,000,000 | 1,649,000,000 | 1,608,000,000 | 1,580,000,000 | 1,588,000,000 | 1,616,000,000 | 1,580,000,000 | 1,574,000,000 | 1,948,000,000 | 1,933,000,000 | 1,919,000,000 | 1,850,000,000 | 1,792,000,000 | 1,770,000,000 | 2,159,000,000 | 2,097,000,000 | 2,119,000,000 |
net property, plant and equipment | 1,201,000,000 | 1,201,000,000 | 1,220,000,000 | 1,234,000,000 | 1,303,000,000 | 1,294,000,000 | 1,340,000,000 | 1,367,000,000 | 1,373,000,000 | 1,354,000,000 | 1,351,000,000 | 1,346,000,000 | 1,338,000,000 | 1,352,000,000 | 1,380,000,000 | 1,401,000,000 | 1,427,000,000 | 1,524,000,000 | 1,532,000,000 | 1,562,000,000 | 1,565,000,000 | 1,554,000,000 | 1,564,000,000 | 1,575,000,000 | 1,577,000,000 | 1,580,000,000 | 1,587,000,000 | 1,621,000,000 | 1,899,000,000 | 1,893,000,000 | 1,940,000,000 | 1,945,000,000 | 1,970,000,000 | 1,937,000,000 | 2,205,000,000 | 2,186,000,000 | 2,224,000,000 |
goodwill - note g | 705,000,000 | 705,000,000 | 1,356,000,000 | 1,330,000,000 | 1,381,000,000 | 1,352,000,000 | 1,362,000,000 | 1,383,000,000 | 1,385,000,000 | 1,369,000,000 | 1,356,000,000 | 1,404,000,000 | 1,411,000,000 | 1,901,000,000 | 1,760,000,000 | 1,792,000,000 | 1,734,000,000 | 1,723,000,000 | 2,274,000,000 | 2,285,000,000 | 2,279,000,000 | 2,289,000,000 | 2,447,000,000 | 2,503,000,000 | 2,475,000,000 | 2,426,000,000 | 2,413,000,000 | 2,348,000,000 | |||||||||
intangibles - note g | 563,000,000 | 578,000,000 | 580,000,000 | 588,000,000 | 751,000,000 | 761,000,000 | 886,000,000 | 916,000,000 | 940,000,000 | 959,000,000 | 1,001,000,000 | 1,041,000,000 | 1,068,000,000 | 1,133,000,000 | 971,000,000 | 1,001,000,000 | 1,026,000,000 | 1,044,000,000 | 1,072,000,000 | 1,118,000,000 | 1,135,000,000 | 1,159,000,000 | 1,249,000,000 | 1,290,000,000 | 1,298,000,000 | 1,316,000,000 | 1,017,000,000 | 1,026,000,000 | |||||||||
operating lease assets, net - note j | 103,000,000 | 114,000,000 | 122,000,000 | ||||||||||||||||||||||||||||||||||
restricted investments - note e | 297,000,000 | 283,000,000 | 272,000,000 | 277,000,000 | 295,000,000 | 287,000,000 | 290,000,000 | 321,000,000 | 349,000,000 | 343,000,000 | 346,000,000 | 387,000,000 | 390,000,000 | 315,000,000 | 302,000,000 | 316,000,000 | 297,000,000 | 277,000,000 | 314,000,000 | 310,000,000 | 296,000,000 | 279,000,000 | 304,000,000 | 303,000,000 | 315,000,000 | 299,000,000 | 298,000,000 | 297,000,000 | |||||||||
asbestos insurance receivable, net(b) - notes a and m | 127,000,000 | ||||||||||||||||||||||||||||||||||||
deferred income taxes - note k | 157,000,000 | 210,000,000 | 22,000,000 | ||||||||||||||||||||||||||||||||||
other assets - note i | 253,000,000 | 264,000,000 | 251,000,000 | ||||||||||||||||||||||||||||||||||
total noncurrent assets | 3,406,000,000 | 3,497,000,000 | 4,158,000,000 | 4,162,000,000 | 4,450,000,000 | 4,362,000,000 | 4,521,000,000 | 4,501,000,000 | 4,433,000,000 | 4,503,000,000 | 4,552,000,000 | 4,535,000,000 | 4,445,000,000 | 4,595,000,000 | 4,755,000,000 | 4,815,000,000 | 4,895,000,000 | 5,531,000,000 | 5,246,000,000 | 5,361,000,000 | 5,330,000,000 | 5,316,000,000 | 5,323,000,000 | 5,982,000,000 | 5,818,000,000 | 5,888,000,000 | 5,911,000,000 | 5,952,000,000 | 6,540,000,000 | 6,552,000,000 | 6,728,000,000 | 6,691,000,000 | 6,715,000,000 | 6,667,000,000 | 6,809,000,000 | 6,729,000,000 | 6,831,000,000 |
total assets | 4,611,000,000 | 4,621,000,000 | 5,233,000,000 | 5,231,000,000 | 5,645,000,000 | 5,747,000,000 | 5,948,000,000 | 5,866,000,000 | 5,939,000,000 | 6,029,000,000 | 6,183,000,000 | 6,259,000,000 | 6,213,000,000 | 6,412,000,000 | 6,780,000,000 | 6,549,000,000 | 6,612,000,000 | 6,766,000,000 | 6,664,000,000 | 6,742,000,000 | 6,877,000,000 | 6,986,000,000 | 6,968,000,000 | 7,326,000,000 | 7,251,000,000 | 7,925,000,000 | 7,998,000,000 | 7,943,000,000 | 8,252,000,000 | 8,224,000,000 | 8,441,000,000 | 8,655,000,000 | 8,618,000,000 | 8,506,000,000 | 9,186,000,000 | 9,063,000,000 | 9,697,000,000 |
liabilities and equity | |||||||||||||||||||||||||||||||||||||
current liabilities | |||||||||||||||||||||||||||||||||||||
trade and other payables | 189,000,000 | 185,000,000 | 185,000,000 | 184,000,000 | 214,000,000 | 198,000,000 | 207,000,000 | 202,000,000 | 210,000,000 | 210,000,000 | 246,000,000 | 246,000,000 | 265,000,000 | 241,000,000 | 248,000,000 | 236,000,000 | 236,000,000 | 236,000,000 | 217,000,000 | 217,000,000 | 233,000,000 | 225,000,000 | 255,000,000 | 234,000,000 | 313,000,000 | 275,000,000 | 280,000,000 | 277,000,000 | 483,000,000 | 397,000,000 | 387,000,000 | 382,000,000 | 409,000,000 | 392,000,000 | 520,000,000 | 458,000,000 | 541,000,000 |
accrued expenses and other liabilities | 213,000,000 | 216,000,000 | 209,000,000 | 207,000,000 | 256,000,000 | 230,000,000 | 225,000,000 | 190,000,000 | 208,000,000 | 201,000,000 | 206,000,000 | 200,000,000 | 269,000,000 | 291,000,000 | 541,000,000 | 214,000,000 | 251,000,000 | 241,000,000 | 241,000,000 | 252,000,000 | 277,000,000 | 238,000,000 | 218,000,000 | 245,000,000 | 271,000,000 | 241,000,000 | 232,000,000 | 257,000,000 | 338,000,000 | 263,000,000 | 266,000,000 | 266,000,000 | 324,000,000 | 274,000,000 | 406,000,000 | 451,000,000 | 486,000,000 |
current operating lease obligations - note j | 21,000,000 | 20,000,000 | 22,000,000 | ||||||||||||||||||||||||||||||||||
total current liabilities | 423,000,000 | 420,000,000 | 463,000,000 | 425,000,000 | 490,000,000 | 464,000,000 | 453,000,000 | 414,000,000 | 456,000,000 | 432,000,000 | 472,000,000 | 464,000,000 | 553,000,000 | 550,000,000 | 810,000,000 | 908,000,000 | 934,000,000 | 602,000,000 | 569,000,000 | 585,000,000 | 813,000,000 | 937,000,000 | 972,000,000 | 688,000,000 | 757,000,000 | 1,007,000,000 | 920,000,000 | 906,000,000 | 1,075,000,000 | 742,000,000 | 712,000,000 | 1,003,000,000 | 968,000,000 | 895,000,000 | 1,037,000,000 | 1,016,000,000 | 1,216,000,000 |
noncurrent liabilities | |||||||||||||||||||||||||||||||||||||
long-term debt - note h | 1,384,000,000 | 1,382,000,000 | 1,336,000,000 | 1,313,000,000 | 1,349,000,000 | 1,325,000,000 | 1,314,000,000 | 1,328,000,000 | 1,328,000,000 | 1,316,000,000 | 1,302,000,000 | 1,336,000,000 | 1,580,000,000 | 1,578,000,000 | 1,571,000,000 | 1,601,000,000 | 1,547,000,000 | 1,535,000,000 | 1,502,000,000 | 2,275,000,000 | 2,275,000,000 | 2,275,000,000 | 2,450,000,000 | 2,579,000,000 | 2,584,000,000 | 2,584,000,000 | 2,812,000,000 | 2,825,000,000 | |||||||||
asbestos litigation reserves - note m | 389,000,000 | ||||||||||||||||||||||||||||||||||||
employee benefit obligations - note l | 96,000,000 | 110,000,000 | 100,000,000 | ||||||||||||||||||||||||||||||||||
operating lease obligations - note j | 85,000,000 | 99,000,000 | 106,000,000 | ||||||||||||||||||||||||||||||||||
other liabilities - note i | 299,000,000 | 286,000,000 | 291,000,000 | ||||||||||||||||||||||||||||||||||
total noncurrent liabilities | 2,284,000,000 | 2,312,000,000 | 2,211,000,000 | 2,214,000,000 | 2,287,000,000 | 2,316,000,000 | 2,361,000,000 | 2,399,000,000 | 2,386,000,000 | 2,448,000,000 | 2,444,000,000 | 2,477,000,000 | 2,440,000,000 | 2,596,000,000 | 2,589,000,000 | 2,878,000,000 | 2,926,000,000 | 2,962,000,000 | 2,981,000,000 | 3,035,000,000 | 3,028,000,000 | 3,036,000,000 | 3,013,000,000 | 3,013,000,000 | 2,923,000,000 | 3,701,000,000 | 3,716,000,000 | 3,732,000,000 | 3,771,000,000 | 4,083,000,000 | 4,218,000,000 | 4,253,000,000 | 4,244,000,000 | 4,212,000,000 | 5,006,000,000 | 5,046,000,000 | 5,316,000,000 |
commitments and contingencies - notes j and m | |||||||||||||||||||||||||||||||||||||
equity - notes n and o | |||||||||||||||||||||||||||||||||||||
common stock | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||
issued 46 million and 47 million shares in 2025 and 2024 | |||||||||||||||||||||||||||||||||||||
paid-in capital | 6,000,000 | 4,000,000 | 135,000,000 | 327,000,000 | 769,000,000 | 756,000,000 | 946,000,000 | 931,000,000 | 923,000,000 | ||||||||||||||||||||||||||||
retained earnings | 2,298,000,000 | 3,315,000,000 | 3,595,000,000 | 3,653,000,000 | 2,796,000,000 | 2,649,000,000 | 3,224,000,000 | 2,750,000,000 | 2,696,000,000 | 2,704,000,000 | |||||||||||||||||||||||||||
accumulated other comprehensive loss | -401,000,000 | -448,000,000 | -503,000,000 | -569,000,000 | -372,000,000 | -383,000,000 | -410,000,000 | -291,000,000 | |||||||||||||||||||||||||||||
total equity | 1,904,000,000 | 2,868,000,000 | 3,097,000,000 | 3,220,000,000 | 2,752,000,000 | 3,036,000,000 | 3,571,000,000 | 3,406,000,000 | 3,406,000,000 | 3,399,000,000 | 3,143,000,000 | 3,001,000,000 | 3,165,000,000 | ||||||||||||||||||||||||
total liabilities and equity | 4,611,000,000 | 5,645,000,000 | 5,939,000,000 | 6,213,000,000 | 6,612,000,000 | 6,877,000,000 | 7,251,000,000 | 8,252,000,000 | 8,618,000,000 | 8,506,000,000 | 9,186,000,000 | 9,063,000,000 | 9,697,000,000 | ||||||||||||||||||||||||
accounts receivable, net(a) - note h | 201,000,000 | 226,000,000 | 163,000,000 | ||||||||||||||||||||||||||||||||||
inventories - note f | 567,000,000 | 542,000,000 | 528,000,000 | 532,000,000 | 712,000,000 | 730,000,000 | 724,000,000 | 609,000,000 | 573,000,000 | 530,000,000 | 517,000,000 | 512,000,000 | 537,000,000 | 617,000,000 | 611,000,000 | 633,000,000 | 595,000,000 | 599,000,000 | 619,000,000 | 656,000,000 | 649,000,000 | 674,000,000 | 631,000,000 | 687,000,000 | 666,000,000 | ||||||||||||
property, plant and equipment | |||||||||||||||||||||||||||||||||||||
operating lease assets, net - note i | 101,000,000 | 98,000,000 | 99,000,000 | 116,000,000 | 126,000,000 | 124,000,000 | 107,000,000 | 112,000,000 | 115,000,000 | 117,000,000 | 134,000,000 | 132,000,000 | 137,000,000 | 140,000,000 | 144,000,000 | 157,000,000 | |||||||||||||||||||||
asbestos insurance receivable, net(b) - note l | 129,000,000 | 126,000,000 | 129,000,000 | ||||||||||||||||||||||||||||||||||
deferred income taxes | 241,000,000 | 241,000,000 | 241,000,000 | 160,000,000 | 150,000,000 | 45,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | 30,000,000 | 30,000,000 | 30,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 24,000,000 | 24,000,000 | 23,000,000 | 28,000,000 | 28,000,000 | 28,000,000 | 28,000,000 | 35,000,000 | 199,000,000 | 199,000,000 | ||||||||||||
liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||||||
current operating lease obligations - note i | 19,000,000 | 19,000,000 | 20,000,000 | 21,000,000 | 21,000,000 | 20,000,000 | 18,000,000 | 18,000,000 | 21,000,000 | 22,000,000 | 24,000,000 | 23,000,000 | 23,000,000 | 23,000,000 | 23,000,000 | 24,000,000 | |||||||||||||||||||||
asbestos litigation reserve - note l | 404,000,000 | 391,000,000 | 401,000,000 | 427,000,000 | 437,000,000 | 443,000,000 | 454,000,000 | 483,000,000 | 462,000,000 | 472,000,000 | 501,000,000 | 489,000,000 | 498,000,000 | 525,000,000 | 530,000,000 | 540,000,000 | |||||||||||||||||||||
employee benefit obligations - note k | 111,000,000 | 110,000,000 | 110,000,000 | 97,000,000 | 108,000,000 | 110,000,000 | 110,000,000 | 137,000,000 | 140,000,000 | 145,000,000 | 158,000,000 | 152,000,000 | 157,000,000 | 152,000,000 | 151,000,000 | 152,000,000 | |||||||||||||||||||||
operating lease obligations - note i | 84,000,000 | 82,000,000 | 83,000,000 | 100,000,000 | 109,000,000 | 108,000,000 | 95,000,000 | 100,000,000 | 102,000,000 | 104,000,000 | 118,000,000 | 119,000,000 | 124,000,000 | 126,000,000 | 131,000,000 | 143,000,000 | |||||||||||||||||||||
other liabilities | 303,000,000 | 263,000,000 | 279,000,000 | 324,000,000 | 288,000,000 | 293,000,000 | 290,000,000 | 280,000,000 | 326,000,000 | 356,000,000 | 331,000,000 | 339,000,000 | 364,000,000 | 421,000,000 | 433,000,000 | 438,000,000 | 416,000,000 | 426,000,000 | 419,000,000 | 426,000,000 | 433,000,000 | 573,000,000 | 541,000,000 | 409,000,000 | 361,000,000 | 445,000,000 | 438,000,000 | ||||||||||
commitments and contingencies - note l | |||||||||||||||||||||||||||||||||||||
stockholders’ equity - note n | 1,889,000,000 | 2,559,000,000 | 2,592,000,000 | 2,967,000,000 | 3,149,000,000 | 3,267,000,000 | 3,318,000,000 | 3,266,000,000 | 3,381,000,000 | 2,763,000,000 | |||||||||||||||||||||||||||
total liabilities and stockholders' equity | 4,621,000,000 | 5,233,000,000 | 5,231,000,000 | 5,747,000,000 | 5,948,000,000 | 5,866,000,000 | 6,029,000,000 | 6,183,000,000 | 6,259,000,000 | 6,412,000,000 | 6,780,000,000 | 6,549,000,000 | 6,766,000,000 | 6,664,000,000 | 6,742,000,000 | 6,986,000,000 | 6,968,000,000 | 7,326,000,000 | 7,925,000,000 | 7,998,000,000 | 7,943,000,000 | 8,224,000,000 | 8,441,000,000 | 8,655,000,000 | |||||||||||||
short-term debt - note h | 50,000,000 | 16,000,000 | 376,000,000 | 95,000,000 | 85,000,000 | 93,000,000 | 446,000,000 | 471,000,000 | 179,000,000 | 332,000,000 | 261,000,000 | 229,000,000 | 82,000,000 | 59,000,000 | 355,000,000 | 223,000,000 | 95,000,000 | 92,000,000 | |||||||||||||||||||
current assets held for sale - note b | 32,000,000 | 41,000,000 | 4,000,000 | 604,000,000 | 61,000,000 | 64,000,000 | 60,000,000 | ||||||||||||||||||||||||||||||
current liabilities held for sale - note b | 14,000,000 | 15,000,000 | 47,000,000 | 5,000,000 | 5,000,000 | 6,000,000 | |||||||||||||||||||||||||||||||
accounts receivable(a) - notes a and h | 243,000,000 | ||||||||||||||||||||||||||||||||||||
asbestos insurance receivable(b) - notes a and m | 132,000,000 | ||||||||||||||||||||||||||||||||||||
asbestos litigation reserve - note m | 414,000,000 | 427,000,000 | |||||||||||||||||||||||||||||||||||
issued 47 million and 51 million shares in 2024 and 2023 | |||||||||||||||||||||||||||||||||||||
accounts receivable(a) - note h | 224,000,000 | ||||||||||||||||||||||||||||||||||||
asbestos insurance receivable(b) - note l | 136,000,000 | ||||||||||||||||||||||||||||||||||||
accounts receivable(a) - note g | 260,000,000 | 194,000,000 | |||||||||||||||||||||||||||||||||||
inventories - note e | 550,000,000 | 588,000,000 | |||||||||||||||||||||||||||||||||||
goodwill - note f | 1,379,000,000 | 1,396,000,000 | |||||||||||||||||||||||||||||||||||
intangibles - note f | 851,000,000 | 875,000,000 | |||||||||||||||||||||||||||||||||||
operating lease assets, net - note h | 117,000,000 | 123,000,000 | |||||||||||||||||||||||||||||||||||
restricted investments - note d | 306,000,000 | 315,000,000 | |||||||||||||||||||||||||||||||||||
asbestos insurance receivable(b) - note k | 121,000,000 | 124,000,000 | |||||||||||||||||||||||||||||||||||
short-term debt - note g | |||||||||||||||||||||||||||||||||||||
current operating lease obligations - note h | 21,000,000 | 22,000,000 | |||||||||||||||||||||||||||||||||||
long-term debt - note g | 1,328,000,000 | 1,341,000,000 | |||||||||||||||||||||||||||||||||||
asbestos litigation reserve - note k | 399,000,000 | 412,000,000 | 576,000,000 | 587,000,000 | 594,000,000 | 631,000,000 | 665,000,000 | 676,000,000 | 702,000,000 | 663,000,000 | 674,000,000 | ||||||||||||||||||||||||||
employee benefit obligations - note j | 97,000,000 | 98,000,000 | 147,000,000 | 145,000,000 | 145,000,000 | 186,000,000 | 190,000,000 | 194,000,000 | 191,000,000 | 1,017,000,000 | 1,040,000,000 | ||||||||||||||||||||||||||
operating lease obligations - note h | 101,000,000 | 107,000,000 | |||||||||||||||||||||||||||||||||||
commitments and contingencies - note k | |||||||||||||||||||||||||||||||||||||
stockholders’ equity - note m | 3,134,000,000 | 3,053,000,000 | 3,217,000,000 | 3,362,000,000 | |||||||||||||||||||||||||||||||||
accounts receivable (a) - notes a and h | 338,000,000 | ||||||||||||||||||||||||||||||||||||
asbestos insurance receivable (b) - notes a and m | 127,000,000 | ||||||||||||||||||||||||||||||||||||
issued 51 million and 54 million shares in 2023 and 2022 | |||||||||||||||||||||||||||||||||||||
accounts receivable (a) - note h | 345,000,000 | 395,000,000 | 351,000,000 | 488,000,000 | 407,000,000 | 340,000,000 | 384,000,000 | ||||||||||||||||||||||||||||||
asbestos insurance receivable (b) - note l | 129,000,000 | 133,000,000 | 135,000,000 | 140,000,000 | 131,000,000 | 132,000,000 | 136,000,000 | 128,000,000 | 130,000,000 | ||||||||||||||||||||||||||||
accounts receivable (a) - notes a and i | 402,000,000 | 369,000,000 | |||||||||||||||||||||||||||||||||||
current assets held for sale - note c | 597,000,000 | 6,000,000 | |||||||||||||||||||||||||||||||||||
property, plant and equipment - note g | |||||||||||||||||||||||||||||||||||||
goodwill - note h | 1,312,000,000 | 1,430,000,000 | 1,758,000,000 | 2,465,000,000 | |||||||||||||||||||||||||||||||||
intangibles - note h | 963,000,000 | 1,099,000,000 | 1,013,000,000 | 1,319,000,000 | |||||||||||||||||||||||||||||||||
operating lease assets, net - note k | 107,000,000 | 124,000,000 | 137,000,000 | ||||||||||||||||||||||||||||||||||
restricted investments - note f | 313,000,000 | 384,000,000 | 301,000,000 | 302,000,000 | |||||||||||||||||||||||||||||||||
asbestos insurance receivable (b) - notes a and n | 138,000,000 | 134,000,000 | |||||||||||||||||||||||||||||||||||
deferred income taxes - note l | 20,000,000 | 30,000,000 | 26,000,000 | 28,000,000 | |||||||||||||||||||||||||||||||||
other assets - note j | 254,000,000 | 267,000,000 | 394,000,000 | 422,000,000 | |||||||||||||||||||||||||||||||||
short-term debt - note i | 365,000,000 | 280,000,000 | 235,000,000 | ||||||||||||||||||||||||||||||||||
current portion of long-term debt | 9,000,000 | ||||||||||||||||||||||||||||||||||||
current operating lease obligations - note k | 19,000,000 | 23,000,000 | 23,000,000 | ||||||||||||||||||||||||||||||||||
current liabilities held for sale - note c | 50,000,000 | ||||||||||||||||||||||||||||||||||||
long-term debt - note i | 1,270,000,000 | 1,596,000,000 | 1,573,000,000 | 2,584,000,000 | |||||||||||||||||||||||||||||||||
asbestos litigation reserve - note n | 472,000,000 | 490,000,000 | 513,000,000 | 694,000,000 | |||||||||||||||||||||||||||||||||
employee benefit obligations - note m | 103,000,000 | 144,000,000 | 157,000,000 | 191,000,000 | |||||||||||||||||||||||||||||||||
operating lease obligations - note k | 94,000,000 | 110,000,000 | 124,000,000 | ||||||||||||||||||||||||||||||||||
other liabilities - note j | 325,000,000 | 349,000,000 | 432,000,000 | 400,000,000 | |||||||||||||||||||||||||||||||||
commitments and contingencies - notes k and n | |||||||||||||||||||||||||||||||||||||
equity - notes o and p | |||||||||||||||||||||||||||||||||||||
issued 54 million and 57 million shares in 2022 and 2021 | |||||||||||||||||||||||||||||||||||||
current portion of long-term debt - note h | 13,000,000 | 6,000,000 | 3,000,000 | 6,000,000 | 16,000,000 | 15,000,000 | |||||||||||||||||||||||||||||||
noncurrent assets held for sale - note c | |||||||||||||||||||||||||||||||||||||
noncurrent liabilities held for sale - note c | |||||||||||||||||||||||||||||||||||||
issued 57 million and 61 million shares in 2021 and 2020 | |||||||||||||||||||||||||||||||||||||
stockholders’ equity | 3,202,000,000 | 3,114,000,000 | 3,122,000,000 | 3,013,000,000 | 2,983,000,000 | 3,625,000,000 | 3,305,000,000 | 3,399,000,000 | 3,511,000,000 | ||||||||||||||||||||||||||||
accounts receivable | 447,000,000 | 409,000,000 | 471,000,000 | 455,000,000 | 498,000,000 | 441,000,000 | 481,000,000 | 507,000,000 | 522,000,000 | 448,000,000 | 681,000,000 | 690,000,000 | 717,000,000 | 597,000,000 | 612,000,000 | 643,000,000 | 972,000,000 | 858,000,000 | 894,000,000 | ||||||||||||||||||
asbestos insurance receivable - note n | 136,000,000 | 209,000,000 | |||||||||||||||||||||||||||||||||||
issued 61 million and 60 million shares in 2020 and 2019 | |||||||||||||||||||||||||||||||||||||
asbestos insurance receivable - note l | 138,000,000 | 145,000,000 | 156,000,000 | ||||||||||||||||||||||||||||||||||
current assets held for sale - note d | 59,000,000 | ||||||||||||||||||||||||||||||||||||
property, plant and equipment - note h | |||||||||||||||||||||||||||||||||||||
goodwill - note i | 2,253,000,000 | 2,449,000,000 | 2,401,000,000 | ||||||||||||||||||||||||||||||||||
intangibles - note i | 1,088,000,000 | 1,225,000,000 | 1,064,000,000 | ||||||||||||||||||||||||||||||||||
restricted investments - note g | 310,000,000 | 312,000,000 | 292,000,000 | ||||||||||||||||||||||||||||||||||
asbestos insurance receivable - note o | 157,000,000 | 179,000,000 | 196,000,000 | ||||||||||||||||||||||||||||||||||
deferred income taxes - note m | 23,000,000 | 28,000,000 | 177,000,000 | ||||||||||||||||||||||||||||||||||
other assets - note k | 410,000,000 | 448,000,000 | 420,000,000 | ||||||||||||||||||||||||||||||||||
noncurrent assets held for sale - note d | |||||||||||||||||||||||||||||||||||||
short-term debt - note j | 166,000,000 | 254,000,000 | 170,000,000 | ||||||||||||||||||||||||||||||||||
current liabilities held for sale - note d | 7,000,000 | ||||||||||||||||||||||||||||||||||||
long-term debt - note j | 1,501,000,000 | 2,275,000,000 | 3,055,000,000 | ||||||||||||||||||||||||||||||||||
asbestos litigation reserve - note o | 555,000,000 | 612,000,000 | 686,000,000 | ||||||||||||||||||||||||||||||||||
employee benefit obligations - note n | 150,000,000 | 179,000,000 | 1,080,000,000 | ||||||||||||||||||||||||||||||||||
other liabilities - note k | 453,000,000 | 426,000,000 | 426,000,000 | ||||||||||||||||||||||||||||||||||
noncurrent liabilities held for sale - note d | |||||||||||||||||||||||||||||||||||||
commitments and contingencies - notes l and o | |||||||||||||||||||||||||||||||||||||
equity - notes p and q | |||||||||||||||||||||||||||||||||||||
issued 60 million and 62 million shares in 2019 and 2018 | |||||||||||||||||||||||||||||||||||||
held for sale - note b | 756,000,000 | 739,000,000 | 713,000,000 | ||||||||||||||||||||||||||||||||||
asbestos insurance receivable - note k | 161,000,000 | 175,000,000 | 178,000,000 | 181,000,000 | 203,000,000 | 205,000,000 | 211,000,000 | 193,000,000 | 194,000,000 | ||||||||||||||||||||||||||||
issued 62 million shares in 2018 and 2017 | 1,000,000 | ||||||||||||||||||||||||||||||||||||
deferred and other income taxes | 28,000,000 | 28,000,000 | |||||||||||||||||||||||||||||||||||
stockholders' equity | 3,399,000,000 | 3,399,000,000 | |||||||||||||||||||||||||||||||||||
current assets of discontinued operations - note e | |||||||||||||||||||||||||||||||||||||
noncurrent assets of discontinued operations - note e | |||||||||||||||||||||||||||||||||||||
current liabilities of discontinued operations - note e | |||||||||||||||||||||||||||||||||||||
noncurrent liabilities of discontinued operations - note e | |||||||||||||||||||||||||||||||||||||
issued 62 million shares in 2017 and 2016 | 1,000,000 | ||||||||||||||||||||||||||||||||||||
total ashland stockholders’ equity | 3,406,000,000 | 3,347,000,000 | |||||||||||||||||||||||||||||||||||
noncontrolling interest | |||||||||||||||||||||||||||||||||||||
current assets of discontinued operations - note d | |||||||||||||||||||||||||||||||||||||
equity and other unconsolidated investments | 32,000,000 | 61,000,000 | 60,000,000 | ||||||||||||||||||||||||||||||||||
noncurrent assets of discontinued operations - note d | |||||||||||||||||||||||||||||||||||||
current liabilities of discontinued operations - note d | |||||||||||||||||||||||||||||||||||||
noncurrent liabilities of discontinued operations - note d | |||||||||||||||||||||||||||||||||||||
equity | |||||||||||||||||||||||||||||||||||||
total ashland stockholders' equity | 3,300,000,000 | 3,175,000,000 | |||||||||||||||||||||||||||||||||||
equity and other unconsolidated investments - note e | 57,000,000 | ||||||||||||||||||||||||||||||||||||
current portion of long-term debt - note j | 19,000,000 | ||||||||||||||||||||||||||||||||||||
issued 62 million shares in 2016 and 67 million shares in 2015 | 1,000,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows provided (used) by operating activities from continuing operations | ||||||||||||||||||||
net income | 32,000,000 | -742,000,000 | 41,000,000 | 56,000,000 | 37,000,000 | -582,000,000 | 32,000,000 | 411,000,000 | 66,000,000 | 76,000,000 | -48,000,000 | 10,000,000 | 35,000,000 | 73,000,000 | -4,000,000 | -57,000,000 | -30,000,000 | 105,000,000 | 10,000,000 | |
loss from discontinued operations, net of income taxes | ||||||||||||||||||||
adjustments to reconcile income from continuing operations to cash flows from operating activities | ||||||||||||||||||||
depreciation and amortization | 50,000,000 | 76,000,000 | 62,000,000 | 62,000,000 | 61,000,000 | 61,000,000 | 61,000,000 | 64,000,000 | 62,000,000 | 82,000,000 | 81,000,000 | 76,000,000 | 75,000,000 | 82,000,000 | 79,000,000 | 83,000,000 | 65,000,000 | 76,000,000 | 77,000,000 | |
original issue discount and debt issuance cost amortization | 2,000,000 | 1,000,000 | 10,000,000 | 3,000,000 | 95,000,000 | |||||||||||||||
deferred income taxes | 68,000,000 | 4,000,000 | -7,000,000 | -5,000,000 | -2,000,000 | -16,000,000 | -12,000,000 | 19,000,000 | -1,000,000 | -1,000,000 | 3,000,000 | -94,000,000 | -7,000,000 | -1,000,000 | 2,000,000 | |||||
gain from sales of property and equipment | -5,000,000 | 0 | 1,000,000 | -4,000,000 | ||||||||||||||||
stock based compensation expense - note o | ||||||||||||||||||||
benefit (loss) from excess tax deduction on stock based compensation | ||||||||||||||||||||
income from restricted investments | -18,000,000 | -23,000,000 | ||||||||||||||||||
loss on acquisitions and divestitures, net - notes b | ||||||||||||||||||||
goodwill impairment | 0 | |||||||||||||||||||
asset impairments | ||||||||||||||||||||
pension contributions | -3,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | |||||||
loss on pension and other postretirement plan remeasurements | ||||||||||||||||||||
change in operating assets and liabilities | -85,000,000 | 68,000,000 | -48,000,000 | 17,000,000 | 62,000,000 | -54,000,000 | -109,000,000 | 3,000,000 | 5,000,000 | -93,000,000 | -44,000,000 | 214,000,000 | 16,000,000 | |||||||
total cash flows from operating activities from continuing operations | 40,000,000 | 140,000,000 | 135,000,000 | 215,000,000 | 52,000,000 | 50,000,000 | 12,000,000 | |||||||||||||
cash flows provided (used) by investing activities from continuing operations | ||||||||||||||||||||
additions to property, plant and equipment | -34,000,000 | -20,000,000 | -25,000,000 | -30,000,000 | -28,000,000 | -37,000,000 | -29,000,000 | -51,000,000 | -33,000,000 | -37,000,000 | -33,000,000 | -83,000,000 | -42,000,000 | |||||||
proceeds from disposal of property, plant and equipment | 5,000,000 | 0 | 0 | 5,000,000 | 5,000,000 | 0 | 0 | 4,000,000 | 3,000,000 | 0 | 0 | 1,000,000 | 1,000,000 | 3,000,000 | ||||||
proceeds from sale or restructuring of operations | 0 | 14,000,000 | ||||||||||||||||||
proceeds from settlement of company-owned life insurance contracts | 7,000,000 | |||||||||||||||||||
company-owned life insurance payments | -4,000,000 | 0 | ||||||||||||||||||
funds restricted for specific transactions | 0 | 0 | ||||||||||||||||||
reimbursement from restricted investments | 8,000,000 | 7,000,000 | 9,000,000 | 10,000,000 | 7,000,000 | 5,000,000 | 12,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | ||||||||||
proceeds from sale of securities | 20,000,000 | 12,000,000 | ||||||||||||||||||
purchase of securities | -42,000,000 | -6,000,000 | -6,000,000 | -4,000,000 | -192,000,000 | 0 | ||||||||||||||
other investing cash flows | ||||||||||||||||||||
total cash flows used by investing activities from continuing operations | -16,000,000 | -4,000,000 | -16,000,000 | -29,000,000 | -20,000,000 | -42,000,000 | -27,000,000 | -25,000,000 | -24,000,000 | -67,000,000 | -35,000,000 | |||||||||
cash flows provided (used) by financing activities from continuing operations | ||||||||||||||||||||
proceeds from (repayment of) short-term debt | -8,000,000 | -187,000,000 | -25,000,000 | 292,000,000 | 14,000,000 | -161,000,000 | 72,000,000 | 37,000,000 | -26,000,000 | 173,000,000 | ||||||||||
repurchase of common stock | 0 | 0 | 0 | |||||||||||||||||
cash dividends paid | -19,000,000 | -19,000,000 | -16,000,000 | -17,000,000 | -17,000,000 | -17,000,000 | -16,000,000 | -16,000,000 | -17,000,000 | -15,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | |||||||
stock based compensation employee withholding taxes paid in cash | 1,000,000 | -1,000,000 | -2,000,000 | -3,000,000 | 0 | -1,000,000 | -5,000,000 | -2,000,000 | 0 | -1,000,000 | -7,000,000 | -2,000,000 | 0 | |||||||
total cash flows used by financing activities from continuing operations | -18,000,000 | -70,000,000 | -207,000,000 | -7,000,000 | -147,000,000 | |||||||||||||||
cash used by continuing operations | 51,000,000 | |||||||||||||||||||
cash used by discontinued operations | ||||||||||||||||||||
operating cash flows | -13,000,000 | -9,000,000 | 21,000,000 | -14,000,000 | -19,000,000 | -62,000,000 | -17,000,000 | 17,000,000 | -58,000,000 | -13,000,000 | -10,000,000 | -13,000,000 | ||||||||
total cash used by discontinued operations | -13,000,000 | -9,000,000 | -63,000,000 | -15,000,000 | 11,000,000 | -60,000,000 | -10,000,000 | |||||||||||||
effect of currency exchange rate changes on cash and cash equivalents | 2,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 1,000,000 | 0 | 0 | 1,000,000 | -1,000,000 | 0 | 0 | -2,000,000 | -1,000,000 | -1,000,000 | ||||||
decrease in cash and cash equivalents | 8,000,000 | 112,000,000 | -43,000,000 | |||||||||||||||||
cash and cash equivalents - beginning of year | ||||||||||||||||||||
cash and cash equivalents - end of year | ||||||||||||||||||||
changes in assets and liabilities | ||||||||||||||||||||
accounts receivable | ||||||||||||||||||||
inventories | ||||||||||||||||||||
trade and other payables | ||||||||||||||||||||
other assets and liabilities | ||||||||||||||||||||
supplemental disclosures | ||||||||||||||||||||
interest paid | ||||||||||||||||||||
income taxes paid | ||||||||||||||||||||
income from discontinued operations, net of income taxes | ||||||||||||||||||||
adjustments to reconcile income from continuing operations to cash flows from operating activities: | ||||||||||||||||||||
original issue discount and debt issuance costs amortization | 2,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 10,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | ||||||||||
income from affiliates | 0 | |||||||||||||||||||
stock based compensation expense | 2,000,000 | 4,000,000 | 4,000,000 | 3,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | 6,000,000 | 7,000,000 | 7,000,000 | 6,000,000 | 7,000,000 | 2,000,000 | 6,000,000 | 6,000,000 | |||||
loss (income) on divestitures | ||||||||||||||||||||
loss on pension plan remeasurements | 0 | |||||||||||||||||||
proceeds from sale of operations | 0 | 1,000,000 | ||||||||||||||||||
reimbursements from restricted investments | 16,000,000 | 5,000,000 | 7,000,000 | |||||||||||||||||
purchases of securities | -12,000,000 | |||||||||||||||||||
total cash flows provided (used) by investing activities from continuing operations | ||||||||||||||||||||
cash flows used by financing activities from continuing operations | ||||||||||||||||||||
repayment of short-term debt | ||||||||||||||||||||
cash provided (used) by continuing operations | 46,000,000 | 22,000,000 | -105,000,000 | 82,000,000 | 259,000,000 | -61,000,000 | -87,000,000 | 4,000,000 | -83,000,000 | -32,000,000 | ||||||||||
cash and cash equivalents - beginning of period | 0 | 0 | 454,000,000 | 0 | 0 | 232,000,000 | 0 | 0 | 294,000,000 | 0 | 0 | 566,000,000 | 0 | 0 | 1,188,000,000 | |||||
cash and cash equivalents - end of period | 39,000,000 | 38,000,000 | 335,000,000 | 63,000,000 | 196,000,000 | 157,000,000 | -32,000,000 | 15,000,000 | 149,000,000 | -43,000,000 | -376,000,000 | 601,000,000 | -113,000,000 | -99,000,000 | 704,000,000 | |||||
loss (income) from discontinued operations, net of income taxes | ||||||||||||||||||||
loss (income) from restricted investments | -7,000,000 | -8,000,000 | -30,000,000 | 28,000,000 | ||||||||||||||||
income on divestitures | ||||||||||||||||||||
impairment charges | ||||||||||||||||||||
total cash flows provided (used) by operating activities from continuing operations | 106,000,000 | |||||||||||||||||||
increase in cash and cash equivalents | 38,000,000 | -119,000,000 | 63,000,000 | 196,000,000 | -75,000,000 | -32,000,000 | 15,000,000 | -145,000,000 | 35,000,000 | |||||||||||
excess tax benefits on stock based compensation | ||||||||||||||||||||
loss from restricted investments | ||||||||||||||||||||
repayment of long-term debt | 0 | -787,000,000 | -2,000,000 | -7,000,000 | -1,000,000 | -176,000,000 | -132,000,000 | |||||||||||||
debt issuance costs | 0 | -1,000,000 | ||||||||||||||||||
cash provided (used) by discontinued operations | ||||||||||||||||||||
investing cash flows | -6,000,000 | -3,000,000 | 0 | -1,000,000 | 2,000,000 | 961,000,000 | 14,000,000 | -6,000,000 | -2,000,000 | |||||||||||
total cash provided (used) by discontinued operations | -17,000,000 | 974,000,000 | ||||||||||||||||||
distributions from equity affiliates | 0 | -3,000,000 | ||||||||||||||||||
loss on early retirement of debt | 0 | 0 | ||||||||||||||||||
income on acquisitions and divestitures, net - notes b | ||||||||||||||||||||
purchase of operations - net of cash acquired | 0 | 0 | ||||||||||||||||||
proceeds from the settlement of derivative instruments | 2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 0 | 0 | 1,000,000 | 0 | 4,000,000 | |||||||||||
proceeds from issuance of long-term debt | 0 | 0 | ||||||||||||||||||
premium on long-term debt repayment | 0 | |||||||||||||||||||
income from discontinued operations | 2,000,000 | 5,000,000 | -384,000,000 | -43,000,000 | -31,000,000 | -23,000,000 | 0 | 1,000,000 | ||||||||||||
stock based compensation expense - note p | ||||||||||||||||||||
income on acquisitions and divestitures - notes b and c | ||||||||||||||||||||
impairments | 0 | 9,000,000 | 0 | 0 | 3,000,000 | |||||||||||||||
net purchases of funds restricted for specific transactions | ||||||||||||||||||||
total cash flows provided (used) by financing activities from continuing operations | -42,000,000 | -50,000,000 | -22,000,000 | 99,000,000 | -10,000,000 | |||||||||||||||
adjustments to reconcile income from continuing operations to | ||||||||||||||||||||
cash flows from operating activities: | ||||||||||||||||||||
(income) income from restricted investments | -33,000,000 | 29,000,000 | -13,000,000 | |||||||||||||||||
excess tax benefit on stock based compensation | 0 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | |||||||||||||||
income on acquisitions and divestitures | ||||||||||||||||||||
net purchase of funds restricted for specific transactions | 0 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | 0 | 0 | -2,000,000 | -2,000,000 | |||||||||||
net income on divestitures | -14,000,000 | 3,000,000 | 0 | 1,000,000 | ||||||||||||||||
proceeds from sales of securities | 42,000,000 | 6,000,000 | 6,000,000 | 4,000,000 | 0 | |||||||||||||||
cash provided (used) by: | ||||||||||||||||||||
operating activities from continuing operations | ||||||||||||||||||||
investing activities from continuing operations | ||||||||||||||||||||
financing activities from continuing operations | ||||||||||||||||||||
discontinued operations | ||||||||||||||||||||
net increase in cash and cash equivalents | ||||||||||||||||||||
income | 13,000,000 | 7,000,000 | 2,000,000 | |||||||||||||||||
distributions to equity affiliates | ||||||||||||||||||||
gain on pension and other postretirement plan remeasurements | 11,000,000 | 0 | 0 | -18,000,000 | ||||||||||||||||
purchase of operations | -1,000,000 | |||||||||||||||||||
payments for the settlement of derivative instruments | 0 | 0 | 0 | -2,000,000 | 0 | 0 | ||||||||||||||
net (income) loss on divestitures | ||||||||||||||||||||
cash flows provided (used) by operating activities from | ||||||||||||||||||||
continuing operations | ||||||||||||||||||||
total cash flows used by operating activities from continuing operations | -34,000,000 | -9,000,000 | ||||||||||||||||||
cash flows provided (used) by investing activities from | ||||||||||||||||||||
cash flows provided (used) by financing activities | ||||||||||||||||||||
from continuing operations | ||||||||||||||||||||
stock based compensation expense - note q | ||||||||||||||||||||
net (income) loss on acquisitions and divestitures - notes c and d | ||||||||||||||||||||
life insurance payments | 0 | 0 | ||||||||||||||||||
financing cash flows | ||||||||||||||||||||
change in cash and cash equivalents held by valvoline | ||||||||||||||||||||
proceeds from sales of operations | ||||||||||||||||||||
distributions from affiliates | ||||||||||||||||||||
adjustments to reconcile income from continuing operations | ||||||||||||||||||||
to cash flows from operating activities | ||||||||||||||||||||
equity income from affiliates | ||||||||||||||||||||
realized gains and investment income on available-for-sale securities | -4,000,000 | -2,000,000 | ||||||||||||||||||
net income on acquisitions and divestitures - notes c and d | ||||||||||||||||||||
proceeds from sale of operations or equity investments | 14,000,000 | |||||||||||||||||||
proceeds from sale of available-for-sale securities | ||||||||||||||||||||
purchase of available-for-sale securities | -9,000,000 | 0 | ||||||||||||||||||
net income on acquisitions and divestitures | ||||||||||||||||||||
gain on post-employment plan remeasurement | ||||||||||||||||||||
proceeds from sales of available-for-sale securities | 0 | 12,000,000 | 5,000,000 | 0 | ||||||||||||||||
premium on long-term debt | ||||||||||||||||||||
gain on early retirement of debt | ||||||||||||||||||||
proceeds (uses) from sale of operations | ||||||||||||||||||||
cash flows from operating activities | ||||||||||||||||||||
deferred and other income taxes | 8,000,000 | |||||||||||||||||||
realized gain and investment income on available-for-sale securities | ||||||||||||||||||||
purchases of available-for-sale securities | ||||||||||||||||||||
cash flows provided (used) by financing activities from | ||||||||||||||||||||
proceeds (repayment) from short-term debt | 120,000,000 | |||||||||||||||||||
excess tax benefits related to share-based payments | 1,000,000 | |||||||||||||||||||
cash transferred to valvoline | ||||||||||||||||||||
gain on available-for-sale securities | ||||||||||||||||||||
net gain on divestitures | 1,000,000 | |||||||||||||||||||
proceeds from short-term debt | ||||||||||||||||||||
cash, beginning of period held by ashland | ||||||||||||||||||||
cash, beginning of period held by valvoline and reported as discontinued operations | ||||||||||||||||||||
loss | ||||||||||||||||||||
proceeds (uses) from sale of operations or equity investments | ||||||||||||||||||||
distributions to noncontrolling interest | ||||||||||||||||||||
uses from sale of operations or equity investments | ||||||||||||||||||||
debt issuance cost amortization | ||||||||||||||||||||
net gain on divestitures - notes b and c | ||||||||||||||||||||
losses on pension and other postretirement plan remeasurements | ||||||||||||||||||||
net proceeds from valvoline inc. initial public offering |